Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-04-16T11:12:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:17:02.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3; no visible changes to study content or navigation.
    Difference
    0.0%
    Check dated 2026-03-11T16:42:39.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added site revision tag v3.4.2; removed the government funding operating-status notice, and these changes do not affect the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:29:29.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide government funding status notice has been added and the site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:40:36.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Glossary toggle added and metadata labels updated (QC criteria status wording and revision version). These are administrative updates that do not alter core study content, eligibility, or results.
    Difference
    0.2%
    Check dated 2026-01-28T00:31:49.000Z thumbnail image

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.